Setup
The proliferation of infections that can not be treated is a nightmare scenario we have not done nearly enough to prevent. Half of all prescriptions written for antibiotics in the US are still inappropriate and new medicines are barely trickling through clinical development. And now comes the MCR-1 gene, which renders bacteria resistant to colistin, the final antibiotic line of defense against recalcitrant infections like CRE. MCR-1’s ability to transfer resistance from one bacterial species to another may ultimately result in untreatable infections. How large is that risk? What will it take to prevent it?
Explore More
Health
To protect our nation’s health, safety and security, it is vital we hold public health prevention and preparedness as a high priority—as high as our nation’s military defense.
The coronavirus is mutating rapidly at the same time people around the world are getting vaccinated. Will the vaccines protect us from the variants?
This week marks one year since the first known COVID-19 death. And while the remarkable pace of vaccine development is widely praised, the lag in its distribution is concernin...
On November 9, 2020, as coronavirus cases surge, President-elect Joe Biden named a COVID-19 Advisory Council. Aspen Ideas has been honored to host several of the council membe...
